• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林相关性肾病:华法林药物遗传学特征的潜在作用

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile.

作者信息

Di Maso Vittorio, Carraro Michele, Bevilacqua Elena, Bucconi Sergio, Artero Mary Louise, Boscutti Giuliano

机构信息

Nephrology and Dialysis Department , AOTS Trieste Hospital , Trieste , Italy.

Nephrology and Dialysis Department , AOTS Trieste Hospital , Trieste , Italy ; Department of Medical Sciences , University of Trieste , Trieste , Italy.

出版信息

Clin Kidney J. 2014 Dec;7(6):605-8. doi: 10.1093/ckj/sfu112. Epub 2014 Oct 28.

DOI:10.1093/ckj/sfu112
PMID:25859382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4389147/
Abstract

Warfarin-related nephropathy (WRN) is a renal complication of warfarin treatment associated with over-anticoagulation. We describe a case of a 73-year-old man affected by chronic kidney disease, essential hypertension and atrial fibrillation treated with warfarin. The patient presented a rapid course of kidney failure after many episodes of over-anticoagulation, and renal biopsy demonstrated WRN. Interestingly, the patient's warfarin pharmacogenetic profile showed that he was warfarin sensitive. This is the first report describing the presence of gene polymorphisms affecting warfarin metabolism in a subject with a biopsy-proven WRN. The patient was treated with corticosteroids obtaining a partial clinical response.

摘要

华法林相关肾病(WRN)是华法林治疗的一种肾脏并发症,与抗凝过度有关。我们描述了一例73岁男性患者,患有慢性肾脏病、原发性高血压和心房颤动,接受华法林治疗。该患者在多次抗凝过度发作后出现快速进展的肾衰竭,肾活检显示为WRN。有趣的是,患者的华法林药物遗传学特征显示他对华法林敏感。这是第一份描述在经活检证实为WRN的患者中存在影响华法林代谢的基因多态性的报告。该患者接受了皮质类固醇治疗,获得了部分临床缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/4389147/21b3113838d7/sfu11201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/4389147/21b3113838d7/sfu11201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/4389147/21b3113838d7/sfu11201.jpg

相似文献

1
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile.华法林相关性肾病:华法林药物遗传学特征的潜在作用
Clin Kidney J. 2014 Dec;7(6):605-8. doi: 10.1093/ckj/sfu112. Epub 2014 Oct 28.
2
Warfarin: A double-edged sword.华法林:一把双刃剑。
J Family Med Prim Care. 2019 Sep 30;8(9):3045-3047. doi: 10.4103/jfmpc.jfmpc_671_19. eCollection 2019 Sep.
3
Warfarin related nephropathy: the first case report in Thailand.华法林相关性肾病:泰国首例病例报告。
J Med Assoc Thai. 2015 Feb;98(2):212-6.
4
Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases.三种不同维生素K拮抗剂所致华法林相关肾病:13例经活检证实病例的分析
Clin Kidney J. 2017 Jun;10(3):381-388. doi: 10.1093/ckj/sfw133. Epub 2017 Feb 8.
5
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.华法林相关性肾病可发生于伴有或不伴有慢性肾脏病的患者中,且与死亡率升高相关。
Kidney Int. 2011 Jul;80(2):181-9. doi: 10.1038/ki.2011.44. Epub 2011 Mar 9.
6
Anticoagulants and acute kidney injury: clinical and pathology considerations.抗凝剂与急性肾损伤:临床与病理相关因素。
Kidney Res Clin Pract. 2014 Dec;33(4):174-80. doi: 10.1016/j.krcp.2014.11.001. Epub 2014 Nov 18.
7
Supratherapeutic International Normalized Ratio causing Nephropathy: A Rare Adverse Effect of Warfarin.超治疗范围的国际标准化比值导致肾病:华法林一种罕见的不良反应
Cureus. 2019 Jul 22;11(7):e5201. doi: 10.7759/cureus.5201.
8
[Warfarin-related nephropathy: a case report].[华法林相关肾病:一例报告]
Rev Med Interne. 2015 Jan;36(1):51-4. doi: 10.1016/j.revmed.2013.09.006. Epub 2013 Dec 3.
9
Warfarin related nephropathy: a case report and review of the literature.华法林相关性肾病:一例病例报告及文献综述
BMC Nephrol. 2016 Feb 1;17:15. doi: 10.1186/s12882-016-0228-4.
10
[Case report: end stage renal disease in a chronic kidney patient on warfarin therapy].[病例报告:一名接受华法林治疗的慢性肾病患者的终末期肾病]
J Bras Nefrol. 2015 Apr-Jun;37(2):275-8. doi: 10.5935/0101-2800.20150043.

引用本文的文献

1
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.IgA肾病是抗凝相关肾病患者最常见的基础疾病。
Kidney Int Rep. 2022 Jan 19;7(4):831-840. doi: 10.1016/j.ekir.2022.01.1048. eCollection 2022 Apr.
2
Anticoagulant-related nephropathy: systematic review and meta-analysis.抗凝相关肾病:系统评价与荟萃分析
Clin Kidney J. 2019 Jan 4;12(3):400-407. doi: 10.1093/ckj/sfy133. eCollection 2019 Jun.
3
Anticoagulant-Related Nephropathy: It's the Real McCoy.抗凝相关肾病:千真万确。

本文引用的文献

1
A pharmacogenetic versus a clinical algorithm for warfarin dosing.基于药理学的华法林剂量调整算法与临床算法的比较。
N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.
2
Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis.CYP2C9和VKORC1基因多态性对华法林治疗患者出血并发症风险的影响:一项系统评价和荟萃分析。
Int J Cardiol. 2013 Oct 9;168(4):4234-43. doi: 10.1016/j.ijcard.2013.07.151. Epub 2013 Aug 7.
3
Anticoagulation and kidney injury: rare observation or common problem?
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):935-937. doi: 10.2215/CJN.02470319. Epub 2019 May 21.
4
Clinical Assessment of Warfarin Therapy in Patients with Maintenance Dialysis-Clinical Efficacy, Risks and Development of Calciphylaxis.维持性透析患者华法林治疗的临床评估——临床疗效、风险及钙化防御的进展
Ann Vasc Dis. 2017 Sep 25;10(3):170-7. doi: 10.3400/avd.ra.17-00062.
5
Warfarin related nephropathy: a case report and review of the literature.华法林相关性肾病:一例病例报告及文献综述
BMC Nephrol. 2016 Feb 1;17:15. doi: 10.1186/s12882-016-0228-4.
6
Acute kidney injury due to glomerular haematuria and obstructive erythrocyte casts associated with thrombocytopaenia and thin basement membrane disease: a case report.因肾小球性血尿和阻塞性红细胞管型导致的急性肾损伤,伴血小板减少症和薄基底膜肾病:一例报告
BMC Nephrol. 2015 Oct 30;16:180. doi: 10.1186/s12882-015-0176-4.
7
Oral anticoagulants and risk of nephropathy.口服抗凝剂与肾病风险
Drug Saf. 2015 Jun;38(6):527-33. doi: 10.1007/s40264-015-0290-z.
抗凝与肾损伤:罕见现象还是常见问题?
J Nephrol. 2013 Jul-Aug;26(4):603-5. doi: 10.5301/jn.5000292. Epub 2013 Jul 10.
4
The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.华法林相关性肾病的发生及其对韩国患者的肾脏和患者结局的影响。
PLoS One. 2013;8(4):e57661. doi: 10.1371/journal.pone.0057661. Epub 2013 Apr 1.
5
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.5/6 肾切除术作为一种经过验证的大鼠模型,可模拟人类华法林相关性肾病。
Am J Nephrol. 2012;35(4):356-64. doi: 10.1159/000337918. Epub 2012 Apr 2.
6
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.口服抗凝治疗期间的出血发生率、临床影响及风险
World J Cardiol. 2011 Nov 26;3(11):351-8. doi: 10.4330/wjc.v3.i11.351.
7
AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences.与大量肾小球性血尿相关的急性肾损伤:临床和病理生理后果。
Clin J Am Soc Nephrol. 2012 Jan;7(1):175-84. doi: 10.2215/CJN.01970211. Epub 2011 Nov 17.
8
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.临床药物遗传学实施联盟 CYP2C9 和 VKORC1 基因分型及华法林剂量指南。
Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7.
9
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.通过减少肾单位和过度抗凝模拟的华法林相关性肾病。
J Am Soc Nephrol. 2011 Oct;22(10):1856-62. doi: 10.1681/ASN.2010101110. Epub 2011 Sep 1.
10
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.华法林相关性肾病可发生于伴有或不伴有慢性肾脏病的患者中,且与死亡率升高相关。
Kidney Int. 2011 Jul;80(2):181-9. doi: 10.1038/ki.2011.44. Epub 2011 Mar 9.